New England Journal of Medicine · 1964 · 94 citations · 12 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacotherapyPulmonary Drug DeliveryPulmonologyAntifungal AgentsAntifungal PharmacologyAntifungal PharmacotherapyAntifungal TherapyInhalation Drug DeliveryPulmonary InfectionsAspergillosis TherapyInvasive Pulmonary Fungal InfectionNystatin TherapyPotassium Iodide AdministrationPulmonary AspergillosisPulmonary Fungal InfectionsRenal Adverse EffectsTreatment Intolerance
EXCEPT for pulmonary resection in selected cases, the therapy of pulmonary aspergillosis has been generally ineffective. Nevertheless, in isolated cases, cures have followed the administration of nystatin by mouth1 and by aerosol2 and the parenteral injection of stilbamidine.3 More recently, the administration of 24 to 30 gm. of potassium iodide by mouth in 2 cases4 and of amphotericin B intravenously in another5 was also thought to be therapeutically effective. However, the drug intolerance and electrolyte imbalance resulting from large doses of iodides taken by mouth4 and the systemic and renal toxic effects of intravenously administered amphotericin6 , 7 prevent a casual approach . . .
12
Pulmonary Alveolar Proteinosis
José Ramírez-R, Walenty M. Nyka, Joseph S. McLaughlin · New England Journal of Medicine · 1963 · 65 citations
Amphotericin B Nephrotoxicity with Irreversible Renal Failure
F Takacs · Annals of Internal Medicine · 1963 · 64 citations
Medicine, Nephrology, Pharmacology +13
Pulmonary Aspergillosis with Cavitation
John P. Utz, James German, Donald B. Louria et al. · New England Journal of Medicine · 1959 · 44 citations